Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
4.21M
-
Shares change
-
+2.05M
-
Total reported value, excl. options
-
$51M
-
Value change
-
+$24.9M
-
Number of buys
-
39
-
Number of sells
-
-6
-
Price
-
$12.12
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q2 2020
49 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q2 2020.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.21M shares
of 120M outstanding shares and own 3.49% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.37M shares), Artal Group S.A. (600K shares), VANGUARD GROUP INC (248K shares), BlackRock Inc. (209K shares), Granite Point Capital Management, L.P. (198K shares), Point72 Asset Management, L.P. (175K shares), CVI Holdings, LLC (163K shares), RENAISSANCE TECHNOLOGIES LLC (160K shares), Parkman Healthcare Partners LLC (140K shares), and FMR LLC (137K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.